Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery

— Contributing to both the Cancer and Inflammation and Immunity Steering Committees —SAN FRANCISCO, June. 4, 2019 (BUSINESS WIRE) – Cofactor Genomics, pioneers in the field of Predictive Immune Modeling, announced today that they have become a member of the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium with the goal of advancing... Read more

Bio-Techne to Acquire B-MoGen Biotechnologies Inc.

JUNE 04, 2019 MINNEAPOLIS, June 4, 2019 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc. The transaction has been completed and is being financed through available cash on hand. “We are very pleased to include the B-MoGen technology in Bio-Techne’s expanding portfolio... Read more

Beckman Coulter Life Sciences Acquires Cytobank

(INDIANAPOLIS, INDIANA – June 4, 2019) – Beckman Coulter Life Sciences today announced its acquisition of Cytobank, a privately held, single cell data analysis, software as a service (SaaS) company based in Santa Clara, California.  Cytobank provides an industry-leading, cloud and machine learning-based software platform for multi-parametric single-cell data analysis, sharing and archiving. The platform accelerates research... Read more

908 Devices broadens the ZipChip platform, brings new capability to biotherapeutics researchers

BOSTON, June 3, 2019 — 908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced several advancements to their ZipChip® product line, which build upon its industry-leading biotherapeutic analysis capabilities in multiple critical application areas. These product and application expansions will be showcased at the 67th Annual ASMS Conference being held in... Read more

Thermo Fisher Scientific Renews Collaboration to Advance Plasma Quantitation Methods in Proteomics

Thermo Fisher Scientific Renews Collaboration to Advance Plasma Quantitation Methods in Proteomics Thermo Fisher and Biognosys to develop industry-leading mass spectrometry-based workflows for the efficient analysis of proteins in complex biological matrices ATLANTA, June 3, 2019 /PRNewswire/ — ASMS 2019 — Thermo Fisher Scientific, the world leader in serving science, and Biognosys, a leading developer of next-generation... Read more

Thermo Fisher Scientific Announces Collaboration to Revolutionize Profiling of Large Plasma Sample Cohorts in Protein-based Clinical Research Studies

Thermo Fisher Scientific Announces Collaboration to Revolutionize Profiling of Large Plasma Sample Cohorts in Protein-based Clinical Research Studies ATLANTA, June 3, 2019 /PRNewswire/ — ASMS 2019 – Thermo Fisher Scientific, the world leader in serving science, and Evosep, a leading provider of sample preparation technologies for protein-based clinical research, have entered into a collaboration to develop... Read more

Thermo Fisher Scientific Announces Collaboration with Newomics to Advance Disease Biomarker Validation

Thermo Fisher Scientific Announces Collaboration with Newomics to Advance Disease Biomarker Validation Thermo Fisher and Newomics to optimize performance of high-throughput analytical workflows ATLANTA, June 3, 2019 /PRNewswire/ — ASMS 2019 — Thermo Fisher Scientific, the world leader in serving science, and Newomics, a leading supplier of microfluidic emitters for liquid chromatography-mass spectrometry (LC-MS) applications, will... Read more

Tecan successfully completes the acquisition of supplier of key parts

Männedorf, Switzerland, May 31, 2019 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of a supplier of key parts. On March 22, 2019, Tecan announced the acquisition of a long-term supplier to vertically integrate the manufacturing of critical precision-machined parts. With two manufacturing sites, one in California,... Read more

NanoString Partners with Multiple Leading Contract Research Organizations to Provide Standardized PanCancer IO 360 Data Analysis Reports

Program Extends Ability of CAP CLIA Labs to Develop a Tumor Inflammation Signature Assay to Support Translational Research by Biopharmaceutical Companies SEATTLE, May 30, 2019 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced commercial partnerships with three Contract Research Organizations (CROs), including Covance, NeoGenomics Laboratories,... Read more

Smiths Detection technology to be deployed in multi-member-state security initiative sponsored by the European Commission

LONDON, UK — 30 May 2019 Smiths Detection’s advanced explosives and chemical trace-detection technology is to be deployed in a broad security initiative that was launched today by the European Commission. Smiths Detection has leased equipment to be used in coordinated, operational trials in public spaces – including transport and other high-risk targets – in multiple European... Read more